Patent intelligence · CA
CA 2453053
UTILISATION DE N2O DANS LE TRAITEMENT DES DETERIORATIONS CELLULAIRES CEREBRALES POST-ISCHEMIQUES
UTILISATION DE N2O DANS LE TRAITEMENT DES DETERIORATIONS CELLULAIRES CEREBRALES POST-ISCHEMIQUES
Patent details — CA 2453053
- Jurisdiction
- CA
- Status
- expired
- Grant date
- Jul 15, 2004
- Expiration
- Jul 10, 2024
- Applicant
- AIR LIQUIDE SANTE INT [FR]
- CPC classes
- A61K 33/ 00 A I, A61K/3300, A61K31/02, A61K33/00
Quick answer
CA 2453053 (UTILISATION DE N2O DANS LE TRAITEMENT DES DETERIORATIONS CELLULAIRES CEREBRALES POST-ISCHEMIQUES) is held by AIR LIQUIDE SANTE INT [FR]. Status: expired. Granted Jul 15, 2004. Expires Jul 10, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AIR LIQUIDE SANTE INT [FR]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 33/ 00 A I, A61K/3300, A61K31/02, A61K33/00, A61K9/72, A61P 25/ 00 A I
More from AIR LIQUIDE SANTE INT [FR]
Related pharmaceutical patents in our USPTO index.
-
US 2016030472
XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY
granted -
CA 2938043
MELANGE GAZEUX NO/HE A ACTION BACTERICIDE
granted -
CA 2866861
TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE
granted -
CA 2853911
PROCEDE DE FABRICATION DE MELANGES GAZEUX NO/N2 DESTINES AU DOMAINE MEDICAL
granted -
CA 2874019
MELANGE GAZEUX NO/AZOTE A TENEUR ELEVEE EN NO POUR TRAITER LES DETRESSES RESPIRATOIRES HYPOXEMIANTES SEVERES
granted -
FR 2964876
COMPOSITION ANESTHESIQUE GAZEUSE A BASE DE XENON UTILISABLE PENDANT UNE ENDARTERIECTOMIE AVEC CLAMPAGE DE L'ARTERE CAROTIDE
granted -
US 2011003857
STABILIZED, ANTIMICROBIALLY EFFECTIVE COMPOSITION WITH A CONTENT OF BISPYRIDINIUM ALKANE
granted -
US 2010331426
Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
granted
Frequently asked questions
What is US patent 2453053?
CA 2453053 (UTILISATION DE N2O DANS LE TRAITEMENT DES DETERIORATIONS CELLULAIRES CEREBRALES POST-ISCHEMIQUES) is held by AIR LIQUIDE SANTE INT [FR]. Status: expired. Granted Jul 15, 2004. Expires Jul 10, 2024 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2453053?
AIR LIQUIDE SANTE INT [FR] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2453053 expire?
Our index shows an expiration date of Jul 10, 2024 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.